At least 20 AngioDynamics port catheter lawsuits have been filed throughout the federal court system, each involving similar problems where the port catheter fractured, became infected or caused other problems.
Woman indicates that information about the risk of fractures and blood clots from Bard PowerPorts was known by the manufacturer for years before she received the port catheter for chemotherapy treatments
Missouri woman indicates that the Bard PowerPort Clearvue failure rate is substantially higher than other port catheters, but information about the risk of complications was concealed by the manufacturer
People of color suffering a pulmonary embolism were more likely to die in hospitals than their white counterparts.
The Rinvoq lawsuit says AbbVie executives mislead investors by failing to disclose safety concerns affecting Xeljanz would also apply to Rinvoq.
Pfizer allegedly knew about the blood clot risks with Xeljanz, but misled patients and the medical community in order to maximize profits.
